|
|
|
|
| LEADER |
00000ctm a2200000ui 4500 |
| 001 |
p2251735 |
| 005 |
20231013110921.0 |
| 008 |
171024s2016 xx a m 000 0 eng d |
| 035 |
|
|
|a (OCoLC)1039096777
|
| 040 |
|
|
|a MPA
|b eng
|e rda
|c MPA
|d UtOrBLW
|
| 049 |
|
|
|a MPAA
|
| 099 |
|
|
|a Ph. D. Thesis 2016
|
| 100 |
1 |
|
|a Varanasi, Ravi.
|
| 245 |
1 |
0 |
|a Utilization of eutectic property of either lidocaine or tetracaine and a chemical permeation enhancer in topical patch development, and the position of the U.S. Food and Drug Administrion on incorporating thermal enhancement in such delivery /
|c Ravi Varanasi.
|
| 264 |
|
0 |
|c 2016.
|
| 300 |
|
|
|a xvii, 256 leaves :
|b illustrations (some color) ;
|c 29 cm
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a "Graduate program in Pharmaceutics"
|
| 502 |
|
|
|a Thesis (Ph. D.)--Massachusetts College of Pharmacy and Health Sciences, 2016.
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 610 |
1 |
0 |
|a United States.
|b Food and Drug Administration.
|0 n 80126147
|
| 650 |
|
0 |
|a Drugs
|x Dosage forms.
|0 sh 85039727
|
| 650 |
|
0 |
|a Transdermal medication.
|0 sh 85043050
|
| 650 |
|
0 |
|a Lidocaine.
|0 sh 85148855
|
| 650 |
|
0 |
|a Skin absorption.
|0 sh 85123190
|
| 650 |
|
7 |
|a Tetracaine.
|2 local
|
| 650 |
|
7 |
|a Trans dermal drug delivery.
|2 local
|
| 650 |
|
7 |
|a Eutectic mixture.
|2 local
|
| 650 |
|
7 |
|a Medication.
|2 homoit
|0 homoit0001007
|
| 650 |
|
7 |
|a Therapies.
|2 homoit
|0 homoit0001366
|
| 951 |
|
|
|a 2251735
|
| 994 |
|
|
|a C0
|b MPA
|
| 999 |
f |
f |
|i b28488b8-1048-5a1d-a005-e2a126c7039b
|s c5d99b99-2447-5ff2-ad14-1a19f43acb41
|t 0
|
| 952 |
f |
f |
|p Can circulate
|a Massachusetts College of Pharmacy and Health Sciences
|b Worcester Campus
|c MCPHS Worcester Library
|d Archives Thesis Collection
|t 0
|e Ph. D. Dissertation 2016
|h Other scheme
|i Book
|m 0113401830782
|
